Korea to designate sibutramine as possible misuse or overuse of drug in October

Published: 2010-07-26 06:59:00
Updated: 2010-07-26 06:59:00
The Korea Food and Drug Administration is considering categorizing sibutramine as drugs that may lead to misuse or overdose to strengthen its inspection for public health in October at the latest.

Under the plan, customers will not get an easier access to sibutramine even at pharmacies where t...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.